...
首页> 外文期刊>AIDS Research and Human Retroviruses >Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa.
【24h】

Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa.

机译:评估BED捕获酶免疫测定法,以估计撒哈拉以南非洲三个国家的成年人中的HIV发病率。

获取原文
获取原文并翻译 | 示例
           

摘要

Serological assays for estimating HIV-1 incidence are prone to misclassification, limiting the accuracy of the incidence estimate. Adjustment factors have been developed and recommended for estimating assay-based HIV-1 incidence in cross-sectional settings. We evaluated the performance of the recommended adjustment factors for estimating incidence in national HIV surveys in three countries in sub-Saharan Africa. The BED-capture enzyme immunoassay was applied to stored blood specimens from (1) pregnant women aged 15-49 years attending antenatal clinics in Cote d'Ivoire (1998-2004), (2) adults aged 15-49 years participating in a demographic health survey in Kenya (2003), and (3) adults aged 15-49 years participating in a national household serosurvey in South Africa (2005). Assay-derived incidence estimates were corrected for misclassification using recommended adjustment factors and, where possible, were compared to mathematically modeled incidence in the same populations. Trends in HIV prevalence were compared to trends in assay-derived incidence to assess plausibility in the assay-derived trends. Unadjusted incidence was 3.8% [95% confidence interval (CI) 3.3-4.5] in Cote d'Ivoire, 3.5% (2.7-4.3) in Kenya, and 4.4% (CI 2.3-6.5]) in South Africa. Adjusted incidence was 2.9% (CI 2.1-3.7) in Cote d'Ivoire, 2.6% (CI 2.0-3.2) in Kenya, and 2.4% (CI 1.7-3.1) in South Africa. After adjustment, peak incidence shifted from older to younger age groups in Cote d'Ivoire and South Africa. Modeled HIV incidence was 1.0% (CI 1.02-1.08) in Kenya and 2.0% (CI 1.7-2.4) in South Africa. After applying the recommended adjustments factors, adjusted assay-derived estimates remained implausibly high in two of three populations evaluated. For more accurate measures of assay-derived population incidence, adjustment factors must be locally derived and validated. Until improved assays are available, caution should be applied in the use and interpretation of data from incidence assays.
机译:用于估计HIV-1发生率的血清学检测方法容易分类错误,从而限制了发生率估计的准确性。已经开发了调整因子,并建议将其用于估计横断面环境中基于测定的HIV-1发生率。我们评估了建议的调整因子在估计撒哈拉以南非洲三个国家的国家艾滋病毒调查中的发病率方面的表现。 BED捕获酶免疫测定法用于(1)在科特迪瓦(1998-2004)产前诊所就诊的15-49岁孕妇,(2)参与人群的15-49岁成年人的血液样本肯尼亚进行的健康调查(2003),以及(3)参加南非全国性家庭血清调查的15-49岁成年人(2005)。使用推荐的调整因子校正因试验得出的发生率估计的错误分类,并在可能的情况下将其与相同人群中数学模拟的发生率进行比较。将HIV流行率趋势与化验衍生发病率趋势进行比较,以评估化验衍生趋势中的合理性。科特迪瓦的未调整发病率是3.8%[95%置信区间(CI)3.3-4.5],肯尼亚是3.5%(2.7-4.3),南非是4.4%(CI 2.3-6.5])。科特迪瓦的调整后发病率是2.9%(CI 2.1-3.7),肯尼亚是2.6%(CI 2.0-3.2),南非是2.4%(CI 1.7-3.1)。经过调整后,科特迪瓦和南非的高峰发病率从老年人群转移到了年轻人群。肯尼亚的模拟HIV发病率为1.0%(CI 1.02-1.08),南非为2.0%(CI 1.7-2.4)。应用建议的调整因子后,在三个评估人群中,有两个人群的调整后分析得出的估算值仍然高得令人难以置信。为了更准确地测定分析得出的人群发生率,必须本地调整因子并进行验证。在改进的测定可用之前,应谨慎使用和解释发生率测定的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号